S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13

Inspire Medical Systems Stock Forecast, Price & News

-15.41 (-6.91%)
(As of 12/3/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
258,191 shs
Average Volume
170,481 shs
Market Capitalization
$5.68 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive INSP News and Ratings via Email

Sign-up to receive the latest news and ratings for Inspire Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

Inspire Medical Systems logo

About Inspire Medical Systems

Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. It offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.


Inspire Investing: Can a Biblical ETF Stand Up to the S&P 500?
November 12, 2021 |  finanznachrichten.de
See More Headlines

Industry, Sector and Symbol

Surgical & medical instruments
Year Founded

Sales & Book Value

Annual Sales
$115.38 million
Book Value
$8.05 per share


Net Income
$-57.20 million
Pretax Margin




Free Float
Market Cap
$5.68 billion

Company Calendar

Last Earnings
Fiscal Year End
Next Earnings (Estimated)


Overall MarketRank

2.01 out of 5 stars

Medical Sector

627th out of 1,388 stocks

Surgical & Medical Instruments Industry

69th out of 126 stocks

Analyst Opinion: 3.4Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

Inspire Medical Systems (NYSE:INSP) Frequently Asked Questions

Is Inspire Medical Systems a buy right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last twelve months. There are currently 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Inspire Medical Systems stock.
View analyst ratings for Inspire Medical Systems
or view top-rated stocks.

How has Inspire Medical Systems' stock price been impacted by Coronavirus (COVID-19)?

Inspire Medical Systems' stock was trading at $75.65 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, INSP stock has increased by 174.4% and is now trading at $207.57.
View which stocks have been most impacted by COVID-19

Are investors shorting Inspire Medical Systems?

Inspire Medical Systems saw a decline in short interest in November. As of November 15th, there was short interest totaling 628,100 shares, a decline of 20.2% from the October 31st total of 786,800 shares. Based on an average daily trading volume, of 192,900 shares, the short-interest ratio is currently 3.3 days. Currently, 2.4% of the shares of the company are sold short.
View Inspire Medical Systems' Short Interest

When is Inspire Medical Systems' next earnings date?

Inspire Medical Systems is scheduled to release its next quarterly earnings announcement on Tuesday, February 22nd 2022.
View our earnings forecast for Inspire Medical Systems

How were Inspire Medical Systems' earnings last quarter?

Inspire Medical Systems, Inc. (NYSE:INSP) posted its quarterly earnings data on Tuesday, November, 2nd. The company reported ($0.38) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.61) by $0.23. Inspire Medical Systems had a negative net margin of 23.45% and a negative trailing twelve-month return on equity of 21.11%. During the same period in the previous year, the company earned ($0.39) earnings per share.
View Inspire Medical Systems' earnings history

What guidance has Inspire Medical Systems issued on next quarter's earnings?

Inspire Medical Systems issued an update on its FY 2021 earnings guidance on Tuesday, November, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $219 million-$221 million, compared to the consensus revenue estimate of $212.94 million.

What price target have analysts set for INSP?

7 equities research analysts have issued 1 year price targets for Inspire Medical Systems' shares. Their forecasts range from $209.00 to $325.00. On average, they anticipate Inspire Medical Systems' stock price to reach $292.80 in the next year. This suggests a possible upside of 41.1% from the stock's current price.
View analysts' price targets for Inspire Medical Systems
or view top-rated stocks among Wall Street analysts.

Who are Inspire Medical Systems' key executives?

Inspire Medical Systems' management team includes the following people:
  • Timothy P. Herbert, President, Chief Executive Officer & Director
  • Philip J. Ebeling, Chief Operating Officer
  • Richard John Buchholz, Chief Financial Officer
  • Quan Ni, Vice President-Research & Clinical Affairs
  • Bryan K. Phillips, Secretary, Chief Compliance Officer & Senior VP

What is Tim Herbert's approval rating as Inspire Medical Systems' CEO?

2 employees have rated Inspire Medical Systems CEO Tim Herbert on Glassdoor.com. Tim Herbert has an approval rating of 100% among Inspire Medical Systems' employees. This puts Tim Herbert in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Inspire Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inspire Medical Systems investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Cisco Systems (CSCO), Bank of America (BAC), DocuSign (DOCU), Pfizer (PFE), Square (SQ), Zynga (ZNGA), CrowdStrike (CRWD) and Johnson & Johnson (JNJ).

When did Inspire Medical Systems IPO?

(INSP) raised $75 million in an initial public offering on Thursday, May 3rd 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs acted as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.

What is Inspire Medical Systems' stock symbol?

Inspire Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "INSP."

Who are Inspire Medical Systems' major shareholders?

Inspire Medical Systems' stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (6.61%), Franklin Resources Inc. (4.03%), Macquarie Group Ltd. (3.92%), Invesco Ltd. (3.31%), William Blair Investment Management LLC (3.28%) and Wasatch Advisors Inc. (2.66%). Company insiders that own Inspire Medical Systems stock include Casey M Tansey, Chau Quang Khuong, Georgia Melenikiotou, Jerry C Griffin, Marilyn C Nelson, Mudit K Jain, Orbimed Advisors Llc, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert.
View institutional ownership trends for Inspire Medical Systems

Which major investors are selling Inspire Medical Systems stock?

INSP stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Principal Financial Group Inc., Balyasny Asset Management LLC, Balyasny Asset Management LLC, Point72 Asset Management L.P., BlackRock Inc., Credit Suisse AG, and Marshall Wace LLP. Company insiders that have sold Inspire Medical Systems company stock in the last year include Georgia Melenikiotou, Randy Ban, and Richard Buchholz.
View insider buying and selling activity for Inspire Medical Systems
or view top insider-selling stocks.

Which major investors are buying Inspire Medical Systems stock?

INSP stock was acquired by a variety of institutional investors in the last quarter, including Macquarie Group Ltd., Wellington Management Group LLP, Lord Abbett & CO. LLC, Frontier Capital Management Co. LLC, William Blair Investment Management LLC, Moore Capital Management LP, Wasatch Advisors Inc., and Bellevue Group AG.
View insider buying and selling activity for Inspire Medical Systems
or or view top insider-buying stocks.

How do I buy shares of Inspire Medical Systems?

Shares of INSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Inspire Medical Systems' stock price today?

One share of INSP stock can currently be purchased for approximately $207.57.

How much money does Inspire Medical Systems make?

Inspire Medical Systems has a market capitalization of $5.68 billion and generates $115.38 million in revenue each year. The company earns $-57.20 million in net income (profit) each year or ($1.74) on an earnings per share basis.

How many employees does Inspire Medical Systems have?

Inspire Medical Systems employs 341 workers across the globe.

What is Inspire Medical Systems' official website?

The official website for Inspire Medical Systems is www.inspiresleep.com.

Where are Inspire Medical Systems' headquarters?

Inspire Medical Systems is headquartered at 5500 WAYZATA BLVD SUITE 1600, GOLDEN VALLEY MN, 55416.

How can I contact Inspire Medical Systems?

Inspire Medical Systems' mailing address is 5500 WAYZATA BLVD SUITE 1600, GOLDEN VALLEY MN, 55416. The company can be reached via phone at (844) 672-4357 or via email at [email protected]ors.com.

This page was last updated on 12/4/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.